1. Role of ProEx C immunocytochemistry in cervical high-grade squamous intraepithelial lesions detection
- Author
-
Carmen, Ungureanu, Demetra Gabriela, Socolov, Gabriela, Anton, Eugenia, Moroşan, Laura Mihaela, Trandafir, Ludmila, Lozneanu, Mioara Florentina, Trandafirescu, and Elena, Cojocaru
- Subjects
Vaginal Smears ,Embryology ,Squamous Intraepithelial Lesions ,Uterine Cervical Neoplasms ,Cell Biology ,General Medicine ,Uterine Cervical Dysplasia ,Immunohistochemistry ,Pathology and Forensic Medicine ,Humans ,Female ,Papillomaviridae ,Developmental Biology ,Papanicolaou Test - Abstract
Screening programs using Papanicolaou smear along with human papillomavirus (HPV) testing led to a significantly decrease of cervical cancer rates. Nevertheless, both assessments have limited specificity for revealing cervical high-grade lesions. The main problem is how to identify the real precursor of cervical squamous cell carcinomas (SCC), namely high-grade squamous intraepithelial lesions (HSIL).The aim of our study was to conclude if ProEx C might be used as a marker for high-grade cervical intraepithelial neoplasia (CIN).In this study, we detected the immunochemical expression of anti-ProEx C antibody in liquid-based cytology (LBC) samples. We analyzed a total number of 125 cervical cytology specimens.In 48% of all cases, ProEx C was found to be positive. The percentage increased from 0% in negative for intraepithelial lesion or malignancy (NILM) cases to 100% in SCC cases.ProEx C may be utilized to improve the accuracy of cytological diagnosis on cervical smears, according to the findings of this study. This marker is also useful in detecting unrevealed high-grade lesions on atypical squamous cells of undetermined significance (ASC-US), low-grade squamous intraepithelial lesions (LSIL) smears, being very useful in establishing the conduct of these cases.
- Published
- 2022